Tisagenlecleucel (Kymriah®) Coverage Criteria
Customize your policy alerts
Sign up for blue cross blue shield - tennessee Policy ID_CHS_22942026_1126 alerts
Get alerted when Policy ID_CHS_22942026_1126 changes without checking for updates manually.
Monitor payer policy activity
This policy governs prior authorization and medical-necessity coverage for tisagenlecleucel (Kymriah) for specified pediatric, young adult, and adult B-cell leukemias and lymphomas. Coverage requires applicable clinical criteria, documentation, and absence of listed exclusions.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.